Japan's mhlw approves padcev® (enfortumab vedotin) for advanced urothelial cancer

Tokyo and bothell, wash., sept. 27, 2021 /prnewswire/ -- astellas pharma inc. (tse:4503, president and ceo: kenji yasukawa, ph.d.
SGEN Ratings Summary
SGEN Quant Ranking